The topic of screening for ovarian cancer is currently evoking a high level of interest, particularly in the families where there appears to be a genetic predisposition. Annual pelvic ultrasound examinations and serum CA-125 levels are performed in these patients but on a population wide basis, ovarian screening has not established itself as producing the ‘pick-up’ rates that would justify its widespread adoption.
